15 May 2023 07:00
Commercial International Bank (Egypt) S.A.E. | ||||
Consolidated Financial Statements Β March 31, 2023 | ||||
Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/3361Z_1-2023-5-14.pdf Β | ||||
Β | ||||||||
Β |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Β | Β |
| Β | Β | Β | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Β | |||||||
Β |
| Β | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Β | Β | ||||||
Β |
Condensed Consolidated Interim Cash flows for the period ended March 31 2023 Β | ||||
Β | ||||
Notes | Mar. 31, 2023 | Β | Mar. 31, 2022 | |
EGP Thousands | Β | EGP Thousands | ||
Β | Β | |||
Cash flow from operating activities | Β | Β | ||
Profit before income tax from continued operations | 8,975,279 | Β | 6,142,091 | |
Profit from discontinued operations | 870 | Β | - | |
Adjustments to reconcile profits to net cash provided by operating activities | Β | Β | Β | |
Fixed assets depreciation | 16 | 228,065 | Β | 223,781 |
Impairment (Released) charge for credit losses (Loans and advances to customers and banks) | Β | 707,740 | Β | (145,266) |
Other provisions charges | 21 | 464,311 | Β | 1,036,252 |
Impairment (Released) charge for credit losses (due from banks) | Β | 2,096 | Β | 4,776 |
Impairment (Released) charge for credit losses (financial investments) | 234,993 | Β | 101,798 | |
Impairment (Released) charge for other assets | - | Β | (277,768) | |
Exchange revaluation differences for financial assets at fair value through OCI and AC | (6,033,831) | Β | 63 | |
Goodwill amortization | 26 | 10,314 | Β | 10,314 |
Intangible assets amortization | 27 | 2,591 | Β | 2,591 |
Utilization of other provisions | 21 | (345) | Β | (156) |
Other provisions no longer used | 21 | - | Β | (385) |
Exchange differences of other provisions | 21 | 1,169,894 | Β | 278,463 |
profits from selling property and equipment | Β | (118) | Β | (50) |
profits from selling financial investments at fair value through OCI | 13 | (70,920) | Β | (1,040,297) |
Shares based payments | Β | 190,974 | Β | 175,235 |
Bank's share in the profits / losses of associates | 14,871 | Β | (2,841) | |
Operating profits before changes in operating assets and liabilities | 5,896,784 | Β | 6,508,601 | |
Β | Β | Β | ||
Net decrease (increase) in assets and liabilities | Β | Β | ||
Due from banks | Β | 12,110,117 | Β | 25,468,271 |
Financial assets at fair value through P&L | Β | - | Β | 239,339 |
Derivative financial instruments | Β | (359,998) | Β | (680,085) |
Loans and advances to banks and customers | 11 - 12 | (17,792,410) | Β | (12,821,977) |
Other assets | Β | (96,139) | Β | 1,844,416 |
Non current assets held for sale | (220,335) | Β | - | |
Due to banks | 17 | 4,790,187 | Β | 2,859,939 |
Due to customers | 18 | 45,212,196 | Β | 21,780,515 |
Current income tax obligations paid | Β | (270,197) | Β | (259,516) |
Non current liabilities held for sale | Β | 890 | Β | - |
Other liabilities | Β | (354,332) | Β | 1,860,904 |
Net cash generated from (used in) operating activities | Β | 48,916,763 | Β | 46,800,407 |
Β | Β | Β | ||
Cash flow from investing activities | Β | Β | ||
Payment for purchases of property, equipment and branches constructions | (457,850) | Β | (92,999) | |
Proceeds from selling property and equipment | 118 | Β | 50 | |
Proceeds from redemption of financial assets at amortized cost | Β | 196,783 | Β | 2,609,283 |
Payment for purchases of financial assets at amortized cost | (8,533,818) | Β | (2,474,553) | |
Payment for purchases of financial assets at fair value through OCI | (32,339,905) | Β | (68,625,535) | |
Proceeds from selling financial assets at fair value through OCI | 46,767,421 | Β | 78,456,150 | |
Payment for investment in subsidiaries. | (1,008,761) | Β | - | |
Net cash generated from (used in) investing activities | 4,623,988 | Β | 9,872,396 | |
Β | Β | Β | Β | |
Β | Β | |||
Β | Β | Β | ||
Condensed Consolidated Interim Cash flows for the period ended March 31, 2023 (Cont.) Β | ||||
Β | ||||
Mar. 31, 2023 | Β | Mar. 31, 2022 | ||
EGP Thousands | Β | EGP Thousands | ||
Β | Β | |||
Cash flow from financing activities | Β | Β | ||
Other loans | Β | 1,607,404 | Β | 1,035,994 |
Dividends paid | Β | (1,988,585) | Β | (4,410,322) |
Issued debt instruments | 612,624 | Β | 253,338 | |
Capital increase | 165,429 | Β | 122,716 | |
Net cash generated from (used in) financing activities | 396,872 | Β | (2,998,274) | |
Β | Β | Β | Β | |
Β | Β | |||
Net (decrease) increase in cash and cash equivalent during the period | 53,937,623 | Β | 53,674,529 | |
Beginning balance of cash and cash equivalent | 92,969,526 | Β | 61,065,822 | |
Cash and cash equivalent at the end of the period | 146,907,149 | Β | 114,740,351 | |
Β | Β | Β | Β | |
Cash and cash equivalent comprise: | Β | Β | ||
Cash and balances at the central bank | Β | 52,462,528 | Β | 30,581,505 |
Due from banks | Β | 170,733,811 | Β | 121,128,084 |
Treasury bills and other governmental notes | 10Β | 68,681,151 | Β | 40,379,000 |
Obligatory reserve balance with CBE | Β | (46,005,523) | Β | (26,188,639) |
Due from banks with maturities more than three months | (29,664,721) | Β | (10,245,456) | |
Treasury bills with maturity more than three months | (69,300,097) | Β | (40,914,143) | |
Total cash and cash equivalent | 146,907,149 | Β | 114,740,351 | |
'
Β
Β
Β
Β
Β
Β | |||||||||||||||
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2022 | Β | ||||||||||||||
Mar. 31, 2022 | Issued and paid up capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders Equity | Non Controlling Interest | Total | |
EGP Thousands | |||||||||||||||
Beginning balance | 19,702,418 | 3,293,074 | 28,260,532 | 1,550,906 | 8,183 | 16,000 | 641,372 | 9,141 | 13,696,402 | 1,674,392 | (4,218) | 68,848,202 | 454,535 | 69,302,737 | |
Capital increase | 122,716 | - | 502,922 | - | - | - | - | - | - | (502,922) | - | 122,716 | - | 122,716 | |
Transferred to reserves | - | 670,872 | 8,333,404 | - | - | 2,947 | - | - | (9,007,223) | - | - | - | - | - | |
Dividends paid | - | - | - | - | - | - | - | - | (4,410,322) | - | - | (4,410,322) | - | (4,410,322) | |
Net profit of the period | - | - | - | - | - | - | - | - | 4,244,231 | - | - | 4,244,231 | 15,387 | 4,259,618 | |
Β Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | (4,201) | - | 4,201 | - | - | - | - | - | |
Net unrealized gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | - | (3,961,167) | - | - | - | - | (3,961,167) | - | (3,961,167) | |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 2,840 | (2,840) | - | - | - | - | - | |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 101,602 | - | - | - | - | 101,602 | - | 101,602 | |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 175,235 | - | 175,235 | - | 175,235 | |
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | 56,854 | 56,854 | 39,279 | 96,133 | |
Balance at the end of the period | 19,825,134 | 3,963,946 | 37,096,858 | 1,550,906 | 8,183 | 18,947 | (3,222,394) | 11,981 | 4,524,449 | 1,346,705 | 52,636 | 65,177,351 | 509,201 | 65,686,552 | |
Β Β Β Β Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2023 Β | Β | ||||||||||||||
Β | Β | ||||||||||||||
Mar. 31, 2023 | Issued and paid up capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders Equity | Non Controlling Interest | Total | |
Β | EGP Thousands | ||||||||||||||
Beginning balance | 29,825,134 | 3,963,946 | 27,096,858 | 1,550,906 | 8,183 | 18,947 | (13,188,818) | 11,981 | 16,393,841 | 1,895,435 | 181,324 | 67,757,737 | 580,431 | 68,338,168 | |
Capital increase | 165,429 | - | - | - | - | - | - | - | - | - | - | 165,429 | - | 165,429 | |
Transferred to reserves | - | 806,408 | 11,998,639 | - | - | 2,208 | - | - | (12,388,223) | (419,032) | - | - | - | - | |
Dividends paid | - | - | - | - | - | - | - | - | (3,738,888) | - | - | (3,738,888) | (23,982) | (3,762,870) | |
Net profit of the period | - | - | - | - | - | - | - | - | 6,064,947 | - | - | 6,064,947 | 3,847 | 6,068,794 | |
Β Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | (1,895) | - | 1,895 | - | - | - | - | - | |
Change in non controlling interest from acquisition of subsidiaries | - | - | - | - | - | - | - | - | - | - | - | - | (536,867) | (536,867) | |
Reserve for transactions under common control | - | - | - | - | (679,155) | - | - | - | - | - | - | (679,155) | - | (679,155) | |
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | - | (8,522,293) | - | - | - | - | (8,522,293) | - | (8,522,293) | |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 3,249 | (3,249) | - | - | - | - | - | |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 208,752 | - | - | - | - | 208,752 | - | 208,752 | |
Β Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 190,974 | - | 190,974 | - | 190,974 | |
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | 100,603 | 100,603 | 99,192 | 199,795 | |
Β Balance at the end of the period Β | 29,990,563 | 4,770,354 | 39,095,497 | 1,550,906 | (670,972) | 21,155 | (21,504,254) | 15,230 | 6,330,323 | 1,667,377 | 281,927 | 61,548,106 | 122,621 | 61,670,727 | |
Β
Follow the stocks